iQ&A for Familial Hypercholesterolemia
iQ&A for SPAF Trials: UPDATE
iQ&A for Thrombosis Risk Reduction
iQ&A for Stroke Prevention in AF
iQ&A for Interventional Cardiology
iQ&A for STEMI Management
iQ&A for Cancer and Thrombosis
iQ&A for Thrombosis Management
iQ&A for DVT and PE
iQ&A for VTE Prophylaxis
iQ&A for Familial Hypercholesterolemia
iQ&A for SPAF Trials: UPDATE
iQ&A for Thrombosis Risk Reduction
iQ&A for Cancer and Thrombosis
iQ&A Stroke for Prevention in AF
iQ&A for VTE Prophylaxis
iQ&A for DVT and PE
iQ&A for Thrombosis Management
iQ&A for STEMI Management
iQ&A for Interventional Cardiology
iQ&A for Sepsis
iQ&A for Alzheimer’s Disease
iQ&A for SPAF Trials: UPDATE
iQ&A for Stroke Prevention in AF
iQ&A for Multiple Sclerosis
iQ&A for Adolescent Depression
iQ&A for Familial Hypercholesterolemia
iQ&A for Type 2 Diabetes
iQ&A for Rheumatoid Arthritis
iQ&A for Cancer and Thrombosis
iQ&A for Sepsis
iQ&A for Alzheimer’s Disease
iQ&A for Adolescent Depression
iQ&A for Familial Hypercholesterolemia
iQ&A for Alzheimer’s Disease
iQ&A for Type 2 Diabetes
iQ&A for Adolescent Depression
Play All
Complete FAQ List
Speakers
Michael H. Schiff, MD
Yusuf Yazici, MD
Mark C. Genovese, MD
Allan Gibofsky, MD, JD
Joel M. Kremer, MD
Eric Ruderman, MD
Daniel E. Furst, MD
Yvonne Sherrer, MD
Theresa A. Lawrence Ford, MD
Resources
Program Content and FAQs
ACR Guidelines for Nonbiologic and Biologic Disease-Modifying Antirheumatic Drugs in RA
Current Evidence for the Management of RA with Biological Disease-Modifying Antirheumatic Drugs
Methotrexate Monotherapy versus Combination Therapy with a Biological Agent in Early RA
Evaluation of Abatacept in Biologic-naive Patients with Active RA
Strategic Approach to the Management of RA with Antirheumatic Drugs
Treatment of RA: Strategies for Optimal Outcomes
Treating RA to Target: International Task Force Recommendations
Updated Consensus Statement on Biological Agents for RA
Submit Questions
About iQ&A
CV Risk Reduction in Setting of Type 2 Diabetes
Stroke Prevention in AF
Metastatic Breast Cancer
Evolving Therapies in MS
Oral Therapy for Type 2 Diabetes
New Frontiers in Metastatic Breast Cancer
ClinicalWebcasts.com
OncologyCAST.net
CardioCAST.net
SepsisCAST.com
HypertensionCAST.com
NeuroPsychCAST.com
Updates in Alzheimer's Disease
Updates in Osteoporosis
Updates in Interventional Cardiology
Updates in Thrombosis
Updates in Parkinson's Disease
Updates in Depression
Landmark Advances in Cardiovascular Anesthesiology
Cancer and Thrombosis Management
Comprehensive Osteoporosis Management
MultipleSclerosisWRAP: Immunomodulation Therapy for Multiple Sclerosis
AntiplateletWRAP: Oral Antiplatelet Therapy and PPIs in ACS and CAD
Alzheimer’sWRAP: Foundation Role of Cholinergic Dysregulation in AD